Text Size

Secondary Prevention Treatment in Patients Who Have Suffered a Cardiovascular Event

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
AstraZeneca
ClinicalTrials.gov Identifier:
NCT01395550
First received: June 14, 2011
Last updated: August 29, 2011
Last verified: August 2011
History of Changes
  Purpose

AstraZeneca was interested in knowing how Cardiologists and Physicians treat patients who have suffered a cardiovascular event.


Condition
Cardiovascular Events

Study Type: Observational
Study Design: Time Perspective: Retrospective
Official Title: Secondary Prevention Treatment in Patients Who Have Suffered a Cardiovascular Event.

Further study details as provided by AstraZeneca:

Enrollment: 88
Study Start Date: January 2010
Study Completion Date: July 2010
Primary Completion Date: July 2010 (Final data collection date for primary outcome measure)
  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Patients with cardiovascular events

Criteria

Inclusion Criteria:

  • All patients who has experienced cardiovascular events

Exclusion Criteria:

  • Patients with no cardiovascular events.
  Contacts and Locations
No Contacts or Locations Provided
  More Information

No publications provided

Responsible Party: AstraZeneca
ClinicalTrials.gov Identifier: NCT01395550     History of Changes
Other Study ID Numbers: NIS-CZA-XXX-2011/1
Study First Received: June 14, 2011
Last Updated: August 29, 2011
Health Authority: South Africa: None

ClinicalTrials.gov processed this record on June 17, 2013